February 26, 2009 - iCAD Inc. reports a 15 percent increase in total revenue in the fourth quarter and for the full year ending Dec. 31, 2008, total revenue increased 41 percent.

Total revenue for the fourth quarter of 2008 was $9.3 million, a 15 percent increase compared with total revenue of $8.1 million for the fourth quarter of 2007. This increase reflects a $1.3 million or 26 percent increase in revenue from the Company’s digital products. In addition to increased digital sales from its OEM partners, the Company also posted higher sales of its comparative reading solution, TotalLook MammoAdvantage which grew 23% over the fourth quarter of 2007.

Total film-based revenue in the fourth quarter of 2008 was essentially flat versus a very strong fourth quarter of 2007. The significant growth attributable to TotalLook MammoAdvantage was largely offset by the decline in film-based CAD product sales. The decrease in service and supply revenue is due to a decline in labor, parts and supplies associated with the Company’s older film-based products. However, service contract revenue grew 10% over the fourth quarter of 2007, and represents 94% of all service and supply revenue as compared to 76% of all service and supply revenue in the prior-year fourth quarter. Moving forward, the Company expects continued growth in service contract revenue as digital CAD systems sales grow and products transition from warranty to service contracts.

The gross margin for the fourth quarter of 2008 expanded to 83.7 percent from 80.5 percent in the prior-year fourth quarter. Operating expenses for the fourth quarter of 2008 increased to $7.5 million from $5.9 million in the fourth quarter of 2007, largely due to costs associated with the product launch of the Company’s new MRI products and investment in the clinical reader study for the Company’s colon CAD product. For the fourth quarter of 2008, the Company posted net income, including stock-based compensation expense of $508,000, of $321,000 or $0.01 per diluted share, compared with net income, including stock-based compensation expense of $387,000, of $525,000 or $0.01 per share in the fourth quarter of 2007. Additionally, the Company generated $2.1 million in cash in the fourth quarter as compared to $491,000 in the fourth quarter of 2007.

For the fourth quarter of 2008, sales of iCAD’s digital products increased 26 percent to $6.3 million from $5.0 million in the prior-year period. Sales of film-based products were relatively flat at $2.2 million, and service and supply revenue declined slightly to $798,000 from $896,000, both compared with the fourth quarter of 2007.

For the year ended December 31, 2008, total revenue increased 41 percent to $37.5 million compared with total revenue of $26.6 million for the year ended December 31, 2007. The gross margin for 2008 expanded to 83.5 percent from 80.2 percent in 2007. Operating expenses for 2008 were $26.5 million compared with operating expenses of $22.5 million incurred during 2007. The increase is largely due to the costs associated with the launch of the Company’s new MRI products and investment in the clinical reader study for the Company’s colon CAD product. Net income for 2008, including stock-based compensation expense of $1.9 million, increased to $4.4 million or $0.10 per diluted share, compared with a net loss, including stock-based compensation expense of $1.2 million, of ($1.6 million) or ($0.04) per share for 2007.

During 2008 sales of iCAD’s digital solutions increased 63 percent to $26.7 million from $16.4 million in 2007. Film-based product sales of $7.4 million were 10 percent higher than the $6.8 million of film-based product sales recorded during 2007. This growth was led by a 40 percent increase in sales of our comparative reading solution, TotalLook MammoAdvantage. While overall service and supply revenue of $3.3 million declined slightly from $3.4 million reported in 2007, service contract revenue grew 16% and represented 88% of all service and supply revenue for the year.

For more information: www.icadmed.com

Related Content

News | Stroke

December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA ...

Time December 01, 2020
arrow
Feature | Artificial Intelligence | Sanjay Parekh, Ph.D. 

February 7, 2020 – At the 2019 Radiological Society of North America (RSNA) meeting in December, there was a record ...

Time February 07, 2020
arrow
News | Computer-Aided Detection Software

January 22, 2020 — The U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image ...

Time January 22, 2020
arrow
News | Artificial Intelligence

October 31, 2019 — Zebra Medical Vision, a deep learning medical imaging analytics company, announced this week a ...

Time October 31, 2019
arrow
Feature | Breast Imaging

October 28, 2019 — Artificial intelligence (AI) helps improve the efficiency and accuracy of an advanced imaging ...

Time October 28, 2019
arrow
News | Artificial Intelligence

Artificial intelligence (AI) software developer Enlitic Inc. announced it has signed a strategic partnership with Select HealthCare Solutions, a developer, owner and operator of cancer centers across the U.S. As part of the agreement, Enlitic will receive access to Select Healthcare’s high-quality, anonymized patient data –– data that will further tune Enlitic’s predictive models for early cancer detection. In turn, Select HealthCare will receive access to Enlitic’s AI software technology and will directly contribute to the development of future Enlitic products in radiology, oncology and pathology.

Time October 24, 2019
arrow
News | Artificial Intelligence

To help advance medical research while preserving data privacy and improving patient outcomes for brain tumor identification, NVIDIA researchers in collaboration with King’s College London researchers recently announced the introduction of the first privacy-preserving federated learning system for medical image analysis. NVIDIA is working with King’s College London and French startup Owkin to enable federated learning for the newly established London Medical Imaging and AI Centre for Value Based Healthcare.

Time October 23, 2019
arrow
News | Artificial Intelligence

Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that its Accipio intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. The integration of Accipio’s AI-powered solutions into Philips CT systems will support the detection of ICH to augment caregivers in identifying and prioritizing patients suffering from stroke, traumatic brain injury, head trauma and other life-threatening conditions.

Time October 18, 2019
arrow
News | Artificial Intelligence

The Radiological Society of North America (RSNA) recently launched its third annual artificial intelligence (AI) challenge: the RSNA Intracranial Hemorrhage Detection and Classification Challenge.

Time October 08, 2019
arrow
News | Artificial Intelligence

Researchers from Intermountain Healthcare and Stanford University say 10 seconds is about how quickly a new system they studied that utilizes artificial intelligence (AI) took to accurately identify key findings in chest X-rays of patients in the emergency department suspected of having pneumonia.

Time September 30, 2019
arrow
Subscribe Now